Ware J, Toomey J R, Stafford D W
Department of Biology, University of North Carolina, Chapel Hill 27599-3280.
Proc Natl Acad Sci U S A. 1988 May;85(9):3165-9. doi: 10.1073/pnas.85.9.3165.
We have used a recombinant DNA epitope library to localize the binding region of a factor VIII (FVIII) monoclonal antibody that neutralizes coagulant activity. The antibody, C5, has previously been described and has been shown to have a FVIII neutralizing potency of 1488 Bethesda units per mg of purified immunoglobulin. A recombinant DNA epitope library was constructed from short, random FVIII cDNA fragments and immunologically screened with C5 to identify bacteriophage expressing the antigenic determinant. The isolation and characterization of immunoreactive bacteriophage restricted the C5 epitope to the overlapping or shared DNA sequence of nine different clones and corresponded to amino acid residues 338-362 of the mature FVIII peptide. The defined epitope is between the proposed activated protein C cleavage site (Arg-336) and thrombin cleavage site (Arg-372) on the amino-terminal 90-kDa FVIII heavy-chain subunit. The identification of the epitope of an inhibiting anti-FVIII antibody between two critical cleavage sites suggests that this amino acid sequence plays a role in regulating FVIII coagulant activity.
我们使用重组DNA表位文库来定位一种能中和凝血活性的凝血因子VIII(FVIII)单克隆抗体的结合区域。该抗体C5此前已有描述,已证明其FVIII中和效力为每毫克纯化免疫球蛋白1488贝塞斯达单位。从短的随机FVIII cDNA片段构建重组DNA表位文库,并用C5进行免疫筛选,以鉴定表达抗原决定簇的噬菌体。免疫反应性噬菌体的分离和表征将C5表位限制在九个不同克隆的重叠或共享DNA序列上,对应于成熟FVIII肽的氨基酸残基338 - 362。确定的表位位于氨基末端90 kDa FVIII重链亚基上拟激活蛋白C切割位点(Arg - 336)和凝血酶切割位点(Arg - 372)之间。在两个关键切割位点之间鉴定出抑制性抗FVIII抗体的表位,表明该氨基酸序列在调节FVIII凝血活性中起作用。